Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
FDA approves Immedia PT System
July 24th, 2005
Farallon Medical, Inc., a California-headquartered developer of point-of-care diagnostic and drug monitoring technologies, announced the United States Food and Drug Administration (FDA) has accepted and cleared for marketing the Immedia PT System. Earlier this year, clinical trials essential for FDA clearance were completed by three medical organizations in the U.S. Farallon Medical's application was submitted in the first quarter of 2005 and the FDA was expeditious in its approval process. "We are very pleased with the results of our clinical trials as well as the rapid and thorough review provided by the FDA," said James McKinley, president and CEO of Farallon...
Source: Medical Letter on the CDC & FDA (2005-07-24)
|
